Vimarsana
Biggest News Aggregation in the World

Page 3 - Dacima Software News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dacima Software. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dacima Software Today - Breaking & Trending Today

Electronic Data Capture Software Market Synopsis 2027 – Global Industry Trends, COVID-19 Impact, Growth Factors, Analysis, Research Report and Outlook | Brandessence Market Research – KSU - Vimarsana News

Electronic Data Capture Software Market Synopsis 2027 – Global Industry Trends, COVID-19 Impact, Growth Factors, Analysis, Research Report and Outlook | Brandessence Market Research – KSU

Global Electronic Data Capture Software Market valued approximately USD XX billion in 2017 and is anticipated to grow with a healthy growth rate of XX% over the forecast period 2018-2025. The Electronic Data Capture Software Market is continuously growing across the world over the coming years. Electronic Data Capture (EDC) leverages different systems, which slightly vary in terms of features and functionalities, to gather clinical trial data in electronic form. A software, it streamlines, and stores patient data accumulated during clinical trials. Data is either procured electronically or f...

Investegate |Montreal Heart Institute Announcements | Montreal Heart Institute: Colchicine reduces the risk of COVID-19-related complications - Vimarsana News

Investegate |Montreal Heart Institute Announcements | Montreal Heart Institute: Colchicine reduces the risk of COVID-19-related complications

Investegate announcements from Montreal Heart Institute, Colchicine reduces the risk of COVID-19-related complications

Colchicine reduces the risk of COVID-19-related complications - Vimarsana News

Colchicine reduces the risk of COVID-19-related complications

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Colchicine reduces the risk of COVID-19-related complications Montreal Heart InstituteJanuary 23, 2021 GMT MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy to treat COVID-19. The study results have shown that colchicine has reduced by 21% the risk of death or hospitalizations in patients with COVID-19 compared to placebo. This result obtained for the g...

Source: apnews.com
Colchicine reduces the risk of COVID-19-related complications Positive results from COLCORONA trial show that colchicine is the only effective oral medication for treating non-hospitalized patients - Vimarsana News

Colchicine reduces the risk of COVID-19-related complications Positive results from COLCORONA trial show that colchicine is the only effective oral medication for treating non-hospitalized patients

Article content MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) — The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy to treat COVID-19. The study results have shown that colchicine has reduced by 21% the risk of death or hospitalizations in patients with COVID-19 compared to placebo. This result obtained for the global study population of 4488 patients approached statistical significance. The analysis of the 4159 patients in whom the diagnosis of COVID-19 was proven by a naso-pharyngeal PCR test...